Aarhus University Seal / Aarhus Universitets segl

AU Career Advisory Panel Health

If you are looking for qualified impartial feedback and guidance in regards to career choices and possible career paths, have a look at the AU Career Advisory Panel Health. 

The panel consists of ten persons who can guide you in relation to career paths within a number of areas. The advisors can receive ten contact requests per year. Once your request has been accepted, you can communicate with the panel participants via phone or e-mail. Personal meetings are also a possibility if you both agree to meet. All conversations are confidential.

Choose your advisor based on the below areas of guidance and learn about the individual panel participants.

Entrepreneurship

  • Trine Winterø, Vice-dean at Faculty of Health Sciences, University of Copenhagen
  • Niels Uth, Patent, Design and Trademark Consultant and CEO at Tropa ApS
  • Torsten Munch-Hansen, Head of Department at Public Health and Quality Improvement, Central Denmark Region
  • Niels Stampe Rüdiger, Managing Director, CEO at AH diagnostics group
  • Poul Sørensen, Chief Scientific Officer and co-founder Allero Therapeutics and Partner at Ventac Partners, 4 Rue Hédouin 92190, Meudon, France

Commercialization and patenting

  • Niels Uth, Patent, Design and Trademark Consultant and CEO at Tropa ApS

The private and public business sector/NGO

  • Brian Stidsen Vandahl, Corporate Vice President, Recombinant Technologies, Global Research Technologies, Novo Nordisk A/S
  • Niels Uth, Patent, Design and Trademark Consultant and CEO at Tropa ApS (to some extent)
  • Niels Stampe Rüdiger, Managing Director, CEO at AH diagnostics group
  • Poul Sørensen, Chief Scientific Officer and co-founder Allero Therapeutics and Partner at Ventac Partners, 4 Rue Hédouin 92190, Meudon, France


Research and education

  • Brian Stidsen Vandahl, Corporate Vice President, Recombinant Technologies, Global Research Technologies, Novo Nordisk A/S
  • Torsten Munch-Hansen, Head of Department at Public Health and Quality Improvement, Central Denmark Region
  • Mette Madsen, Associate Professor at the Department of Biomedicine at AU
  • Niels Stampe Rüdiger, Managing Director, CEO at AH diagnostics group
  • Poul Sørensen, Chief Scientific Officer and co-founder Allero Therapeutics and Partner at Ventac Partners, 4 Rue Hédouin 92190, Meudon, France
  • Vibeke Brix Christensen, Consultant, Department of Paediatric Surgery at Rigshospitalet

The health services

  • Claus Thomsen, Chief Medical Officer, MD, PhD, at Aarhus University Hospital (AUH) 
  • Torsten Munch-Hansen, Head of Department at Public Health and Quality Improvement, Central Denmark Region

International aspects and use of international networks

  • Mette Madsen, Associate Professor at the Department of Biomedicine at AU (to some extent)
  • Niels Stampe Rüdiger, Managing Director, CEO at AH diagnostics group
  • Poul Sørensen, Chief Scientific Officer and co-founder Allero Therapeutics and Partner at Ventac Partners, 4 Rue Hédouin 92190, Meudon, France